Overview

Zolpidem on CPAP Acclimatization in OSA

Status:
Not yet recruiting
Trial end date:
2024-10-15
Target enrollment:
Participant gender:
Summary
Obstructive sleep apnea (OSA) is a sleep disorder characterized by a cessation or significant decrease in airflow during sleep. CPAP is the preferred therapy and has high effectiveness at all levels of OSA severity. It acts as a pneumatic splint to maintain upper airway patency during sleep, preventing the soft tissues from collapsing. However, the patient's compliance continues to be an issue. One of the main contributors to CPAP therapy failure is difficulty falling asleep. To aid in the machine's adaptation, hypnotic medicine was administered.
Phase:
Phase 4
Details
Lead Sponsor:
Siriraj Hospital
Treatments:
Zolpidem